Stéphane Thiroloix

Stéphane Thiroloix has held a variety of positions in the medical and business fields since 2011. From 2011 to 2014, they served as President of Advanced Surgical Devices Europe at Smith & Nephew. From 2013 to 2016, they were a Board Member and Chairman of the Orthopedics Committee at Eucomed. In 2016, they became the President of POLEPHARMA and held that position until 2014 when they became the Chief Executive Officer of MAYOLY SPINDLER. In 2018, they were appointed President & CEO of AlgoTherapeutix and Board Member of Jellagen Pty Ltd. In 2019, they became a Lecturer at ESSEC Business School. In 2021, they were appointed Board & Strategy of NooS. In 2022, they joined the Evaluation Committee of Paris Biotech Santé.

Stéphane Thiroloix attended HEC Paris from 1984 to 1986.